ARCHIVES

BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

March 5, 1999

Organ Systems Coordinating Center Deadline Extended

August 5, 1983

DCBD Board Approved Concepts For New Grants In Cytogenetics Solid Tumor Diagnoses

December 13, 1984

New Version Of NCI Proposed IP Agreement Quiets Some Unease At Cooperative Groups; Advisors Urge “No Paralysis” While Awaiting New Language

November 13, 2009